Brief: Cero Therapeutics Announces $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
Feb 5 (Reuters) - CERo Therapeutics Holdings Inc
CERO.O :
* CERO THERAPEUTICS ANNOUNCES $5 MILLION PUBLIC OFFERING
PRICED
AT-THE-MARKET UNDER NASDAQ RULES
* CERO THERAPEUTICS HOLDINGS INC - PRICES PUBLIC OFFERING AT
$1.96
PER SHARE
Source text: ID:nGNXJj2JL
Further company coverage: CERO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CERo Therapeutics Holdings
See all newsBrief: Cero Therapeutics Hearing Review Council Issued Decision
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Trial Of Cer-1236 In Aml (Certaint-1)
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Trial Of Cer-1236 In Aml
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Clinical Trial
Brief: Cero Therapeutics Holdings Inc - Continues To Evaluate Additional Options For Up-List